Sign In
Buy RGEN
$121.73
+0.600 (+0.495%)
At Close: Jun 03, 2026
Here's Why Repligen (RGEN) is a Strong Growth Stock
01:45pm, Wednesday, 17'th Aug 2022 Zacks Investment Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Repligen (RGEN) is a Strong Growth Stock
11:17am, Wednesday, 17'th Aug 2022
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Catalent-Repligen Merger 'Seems Unlikely,' This Analyst Says
10:30pm, Friday, 12'th Aug 2022 Benzinga
Yesterday, Catalent Inc (NYSE: CTLT) announced to acquire Metrics Contract Services for $475 million.
Keybanc notes that the deal strengthens CTLT's oral delivery portfolio and targets rapidly gro
Why Shares of Repligen Surged This Week
05:57pm, Thursday, 04'th Aug 2022 The Motley Fool
The bioprocessing equipment company is seeing growth prospects accelerate for its non-COVID-related revenue.
Why Shares of Repligen Surged This Week
01:57pm, Thursday, 04'th Aug 2022
The bioprocessing equipment company is seeing growth prospects accelerate for its non-COVID-related revenue.
Repligen (RGEN) Q2 Earnings and Sales Beat Estimates, Stock Up
04:19pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
Repligen (RGEN) reports encouraging second-quarter results, with sales and earnings beating estimates. RGEN also raises its financial guidance for 2022
Expert Ratings for Repligen
04:09pm, Wednesday, 03'rd Aug 2022 Benzinga
Analysts have provided the following ratings for Repligen (NASDAQ:RGEN) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
3
0
0
0
Last 3
Repligen (RGEN) Q2 Earnings and Sales Beat Estimates, Stock Up
01:32pm, Wednesday, 03'rd Aug 2022
Repligen (RGEN) reports encouraging second-quarter results, with sales and earnings beating estimates. RGEN also raises its financial guidance for 2022
Why Shares Of Cannabis Companies Traded Higher; Here Are 101 Biggest Movers From Yesterday
10:07am, Wednesday, 03'rd Aug 2022 Benzinga
Gainers
MMTec, Inc. (NASDAQ: MTC) shares gained 390.6% to close at $7.85 on Tuesday amid volatility in nano-cap Chinese stocks.
Applied DNA Sciences, Inc. (NASDAQ: APDN) surged 296.9% to settle at $2
Uber, Lyft And Some Other Big Stocks Recording Gains On Tuesday
08:16am, Wednesday, 03'rd Aug 2022 Benzinga
U.S. stocks closed lower on Tuesday, with the Dow Jones dropping more than 400 points. Here is the list of some big stocks moving higher in the previous session.
AMTD IDEA Group (NYSE: AMTD) shares
Why Repligen Corporation Stock Is Storming Higher Today
06:56pm, Tuesday, 02'nd Aug 2022 The Motley Fool
Repligen's strong second-quarter results are a hit with investors.
Why Applied DNA Sciences Is Trading Higher By 166%, Here Are 75 Stocks Moving In Tuesday's Mid-Day Session
04:41pm, Tuesday, 02'nd Aug 2022 Benzinga
Gainers
AMTD IDEA Group (NYSE: AMTD) shares jumped 284% to $8.00 after jumping 18% on Monday. The company owns 90%+ of AMTD Digital.
Applied DNA Sciences, Inc. (NASDAQ: APDN) gained 166% to $1.8801
Why Repligen Corporation Stock Is Storming Higher Today
02:56pm, Tuesday, 02'nd Aug 2022
Repligen's strong second-quarter results are a hit with investors.
Repligen (RGEN) Tops Q2 Earnings and Revenue Estimates
12:45pm, Tuesday, 02'nd Aug 2022 Zacks Investment Research
Repligen (RGEN) delivered earnings and revenue surprises of 26.39% and 9.83%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Is a Beat in Store for Gilead (GILD) in This Earnings Season?
02:10pm, Thursday, 28'th Jul 2022 Zacks Investment Research
Investors will focus on the HIV franchise's performance and Veklury sales in Gilead's (GILD) second-quarter 2022 results.
